Clinical and genomic characterization of KRAS G13X non-small cell lung carcinoma

Benjamin J. Staum, Rachaita Lakra, Aditya Ravindra, Sarah L Mott, Deqin Ma, William Zeitler, Margaret Byrne, Nirmal Choradia, Abdul Rafeh Naqash, Raid Aljumaily, Muhammad Furqan · 2026

Read Clinical and genomic characterization of KRAS G13X non-small cell lung carcinoma by Benjamin J. Staum, Rachaita Lakra, Aditya Ravindra, Sarah L Mott, Deqin Ma, William Zeitler, Margaret Byrne, Nirmal Choradia, Abdul Rafeh Naqash, Raid Aljumaily, Muhammad Furqan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581628.txt.

Description

Benjamin Staum and co-authors read, in a 2026 study, a rare codon form of the KRAS gene in lung cancer. KRAS is the top drive gene in this cancer; its codon 13 form, G13X, was near un-read. Files from one Iowa center gave 108 cure-aim and 100 ease-aim patients with KRAS forms. The G13X form held near 10 percent of them. Its tumors ran rich in mate changes: STK11, KEAP1, NFE2L2, and TSC1/2. In the cure-aim set, G13X held the low mark for one-year free span, at 41 percent. Yet the form was no lone call of fate in the math.

Poor shape, stage III, late care start, and no ATM mate tied to worse free span. TET2 shifts tied to worse life.

Catalog record

CREATORBenjamin J. Staum, Rachaita Lakra, Aditya Ravindra, Sarah L Mott, Deqin Ma, William Zeitler, Margaret Byrne, Nirmal Choradia, Abdul Rafeh Naqash, Raid Aljumaily, Muhammad Furqan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13581628

Browse the full library · About the Tower of Babel